Competition Council fines Boehringer Ingelheim RCV RON 128 M for abuse of dominant position
The Competition Council has fined Boehringer Ingelheim RCV GmbH & Co KG (Austria) 128,470,123 lei (€25.81 million) for abusing its dominant position in Romania’s market for medicines treating chronic obstructive pulmonary disease…